2-Amino-3-(methylamino)propanoic acid (BMAA) bioavailability in the primate
- 1 March 1992
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 13 (2) , 333-337
- https://doi.org/10.1016/0197-4580(92)90047-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Synthesis and optical resolution of the neurotoxin 2-amino-3-([15N]-methylamino)propanoic acid (BMAA)Journal of Labelled Compounds and Radiopharmaceuticals, 1990
- Selective degeneration of cerebellar cortical neurons caused by cycad neurotoxin, L‐β‐methylaminoalanine (L‐BMAA), in ratsNeuropathology and Applied Neurobiology, 1990
- CYCADS AND AMYOTROPHIC LATERAL SCLEROSIS/PARKINSONISM DEMENTIAThe Lancet, 1988
- 2-AMINO-3 (METHYLAMINO)-PROPIONIC ACID IN CYCAD-DERIVED FOODS IS AN UNLIKELY CAUSE OF AMYOTROPHIC LATERAL SCLEROSIS/PARKINSONISMThe Lancet, 1988
- Amyotrophic lateral sclerosis and parkinson's disease complex on Guam linked to an environmental neurotoxinTrends in Neurosciences, 1988
- CYCAD USE AND MOTOR NEURONE DISEASE IN KII PENINSULA OF JAPANThe Lancet, 1987
- CYCAD USE AND MOTOR NEURONE DISEASE IN IRIAN JAYAThe Lancet, 1987
- Guam Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Linked to a Plant Excitant NeurotoxinScience, 1987
- Neurodegenerative disorders of the western pacific: the search for mechanisms of pathogenesisTrends in Neurosciences, 1986
- MOTORNEURONE DISEASE ON GUAM: POSSIBLE ROLE OF A FOOD NEUROTOXINThe Lancet, 1986